Vaxcyte, Inc.
Vaxcyte, Inc. (PCVX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PCVX · as of Jun 8, 2026
Key Statistics
Explore Vaxcyte, Inc. Data
pcvx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 100.0%
The PCVX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $89.00, representing +92.56% upside from the current price of $46.22.
Competitors & Peers
pcvx competitorsPCVX
ACLX
AKRO
ALKS
ARWR
CRNXStock Performance
Full HistoryAbout Vaxcyte, Inc.
Vaxcyte, Inc. a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent inve…
what is vaxcyte, inc. · pcvx stock overview · vaxcyte, inc. company profile · who is vaxcyte, inc. ceo · pcvx NASDAQ · vaxcyte, inc. headquarters · vaxcyte, inc. business segments
About Stock Overview & Key Data
Vaxcyte, Inc. (PCVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 12, 2020. As of the latest trading session, PCVX stock price is $46.22, with a market capitalization of $6.7B. The stock has returned +24.29% over the past 12 months and +0.21% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Vaxcyte, Inc. stock is Buy, with an average 12-month price target of $89.00. In fiscal year 2025, Vaxcyte, Inc. reported revenue of — and net income of -$766.6M. For detailed data — including Vaxcyte, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vaxcyte, Inc. (PCVX) stock price is $46.22. The stock is traded on NASDAQ under the ticker symbol PCVX. The 52-week range is $29.08 – $65.00.